Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A medicinal herb native to Southeast Asia, particularly Vietnam, *Adenosma glutinosum* (also known as Adenosma glutinosa) is widely utilized in traditional medicine for its hepatoprotective and immunomodulatory properties. The plant contains a variety of bioactive compounds, including essential oils (such as cineol and limonene) and flavonoids (such as adenosmin). In clinical research settings, it has been investigated as a key component of multi-herb combinations for the treatment of chronic hepatitis B and HIV-1 infection. Its mechanism of action is primarily attributed to its flavonoids, which are thought to protect and repair CD4+ T-lymphocyte cell membranes, reduce cellular inflammation, and support the immune system's response to viral infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on adenosma glutinosum.